Article Details
Retrieved on: 2025-02-25 12:26:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
That same month, Roche's VENTANA FOLR1 RxDx Assay became the first IHC-based companion diagnostic approved by the FDA to identify ovarian cancer ...
Article found on: www.openpr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here